Related Experiment Video
Updated: Apr 25, 2026

04:38
A Murine Tail Lymphedema Model
Published on: February 10, 2021
5.9K
Inflammatory lymphangiogenesis in postpartum breast tissue remodeling
The Journal of Clinical Investigation
|August 19, 2014
Summary
Inhibiting cyclooxygenase-2 (COX-2) during postpartum breast tissue involution reduces inflammation and lymphangiogenesis, thereby decreasing breast cancer metastasis risk in mouse models.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Mammary carcinomas spread through lymphatic vessels, with lymphangiogenesis correlating to tumor dissemination.
- Lactation history impacts breast cancer risk and metastasis, with increased risk observed within 5 years postpartum.
Purpose of the Study:
- To investigate the role of postpartum breast tissue remodeling in lymphangiogenesis and cancer metastasis.
- To evaluate the effect of cyclooxygenase-2 (COX-2) inhibition on these processes.
Main Methods:
- Utilized mouse models to study postpartum breast tissue involution.
- Administered COX-2 inhibitors during involution and assessed lymphangiogenesis and cancer metastasis.
- Analyzed the tumor microenvironment, including immune-suppressive cells.
Main Results:
- Postpartum involution coincided with inflammatory lymphangiogenesis.
- COX-2 inhibition during involution reduced cancer metastasis and lymphangiogenesis.
- COX-2 inhibition decreased immune-suppressive cells like myeloid-derived suppressor cells and regulatory T cells.
Conclusions:
- Inhibiting COX-2 during postpartum involution may reduce breast cancer metastasis.
- Targeting COX-2 offers a potential strategy to mitigate metastasis risk associated with lactation weaning.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Mechanism of Angiogenesis
6.3K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.3K
Chronic Inflammation: Introduction
22
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
22

